Jørgensen L, Bilde T, Kvist Kristensen J, Buchardt Hansen H J
Scand J Urol Nephrol. 1985;19(1):49-53. doi: 10.3109/00365598509180222.
Since 1979 we have used human umbilical vein graft as the ultimate vascular access for hemodialysis in patients with chronic renal failure. In 24 patients 33 graft fistulas were performed. Several complications were encountered. Among these infection was the most serious, occurring in seven grafts. All these grafts were removed and never used for hemodialysis. Thrombosis occurred 25 times, and five grafts were lost because of this, whereas 20 grafts had successful thrombectomy and continued to function. Aneurysm formation occurred four times, two grafts were lost. Stenosis was seen in three cases, one graft was lost. In the material 26 grafts were used for hemodialysis and a median function time of 8.5 months was obtained. At the end of the observation period 10 grafts were open, eight were used for hemodialysis, two were not used because of successful transplantation. The umbilical vein graft is an acceptable alternative as vascular access where conventional methods of fistula formation have been exhausted.
自1979年以来,我们一直将人脐静脉移植物作为慢性肾衰竭患者血液透析的最终血管通路。在24例患者中进行了33次移植物内瘘手术。遇到了几种并发症。其中感染最为严重,7例移植物发生感染。所有这些移植物均被移除,不再用于血液透析。血栓形成发生了25次,5例移植物因此丢失,而20例移植物成功进行了血栓切除术并继续发挥功能。动脉瘤形成发生了4次,2例移植物丢失。3例出现狭窄,1例移植物丢失。在该材料中,26例移植物用于血液透析,获得的中位功能时间为8.5个月。在观察期结束时,10例移植物通畅,8例用于血液透析,2例因成功移植而未使用。在传统造瘘方法已用尽的情况下,脐静脉移植物作为血管通路是一种可接受的替代方法。